RU2008116871A - Органолептически приемлемые пероральные лекарственные формы ибупрофена, способы их приготовления и применения - Google Patents

Органолептически приемлемые пероральные лекарственные формы ибупрофена, способы их приготовления и применения Download PDF

Info

Publication number
RU2008116871A
RU2008116871A RU2008116871/15A RU2008116871A RU2008116871A RU 2008116871 A RU2008116871 A RU 2008116871A RU 2008116871/15 A RU2008116871/15 A RU 2008116871/15A RU 2008116871 A RU2008116871 A RU 2008116871A RU 2008116871 A RU2008116871 A RU 2008116871A
Authority
RU
Russia
Prior art keywords
dosage form
ibuprofen
acid
form according
masking agent
Prior art date
Application number
RU2008116871/15A
Other languages
English (en)
Russian (ru)
Inventor
Тору ХИБИ (US)
Тору Хиби
Original Assignee
ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. (US)
ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. (US), ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. filed Critical ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. (US)
Publication of RU2008116871A publication Critical patent/RU2008116871A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
RU2008116871/15A 2005-11-02 2006-10-17 Органолептически приемлемые пероральные лекарственные формы ибупрофена, способы их приготовления и применения RU2008116871A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73312705P 2005-11-02 2005-11-02
US60/733,127 2005-11-02
US81041706P 2006-06-01 2006-06-01
US60/810,417 2006-06-01

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2012138581/15A Division RU2012138581A (ru) 2005-11-02 2012-09-11 Органолептически приемлемая пероральная лекарственная форма ибупрофена и способы ее приготовления и применения

Publications (1)

Publication Number Publication Date
RU2008116871A true RU2008116871A (ru) 2009-12-10

Family

ID=38023574

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2008116871/15A RU2008116871A (ru) 2005-11-02 2006-10-17 Органолептически приемлемые пероральные лекарственные формы ибупрофена, способы их приготовления и применения
RU2012138581/15A RU2012138581A (ru) 2005-11-02 2012-09-11 Органолептически приемлемая пероральная лекарственная форма ибупрофена и способы ее приготовления и применения

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2012138581/15A RU2012138581A (ru) 2005-11-02 2012-09-11 Органолептически приемлемая пероральная лекарственная форма ибупрофена и способы ее приготовления и применения

Country Status (12)

Country Link
US (1) US20070098789A1 (cg-RX-API-DMAC10.html)
EP (1) EP1942877A4 (cg-RX-API-DMAC10.html)
JP (2) JP2009514857A (cg-RX-API-DMAC10.html)
KR (1) KR20080034166A (cg-RX-API-DMAC10.html)
CN (1) CN103622926A (cg-RX-API-DMAC10.html)
AR (1) AR056749A1 (cg-RX-API-DMAC10.html)
AU (2) AU2006312119B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0618273A2 (cg-RX-API-DMAC10.html)
CA (1) CA2620219A1 (cg-RX-API-DMAC10.html)
RU (2) RU2008116871A (cg-RX-API-DMAC10.html)
TW (1) TW200733954A (cg-RX-API-DMAC10.html)
WO (1) WO2007055887A1 (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2567050C2 (ru) * 2011-07-01 2015-10-27 Сино-Американ Тяньцзинь Смитклайн Энд Френч Лаб., Лтд Жевательная таблетка ибупрофена

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1942877A4 (en) * 2005-11-02 2011-09-14 Teikoku Pharma Usa Inc ORGANOLEPTICALLY ACCEPTABLE ORAL DOSAGE FORMS OF IBUPROFEN, MANUFACTURING METHOD AND APPLICATION
MX2009004439A (es) * 2006-10-25 2009-05-11 Mcneil Ppc Inc Composicion de ibuprofeno.
JP5821247B2 (ja) * 2010-04-07 2015-11-24 大正製薬株式会社 イブプロフェンの昇華抑制方法
CN103635178A (zh) * 2011-04-11 2014-03-12 阿扬达集团 口服药物分散组合物
US9914968B2 (en) 2012-09-26 2018-03-13 Cepheid Honeycomb tube
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
CN103690474B (zh) * 2013-12-04 2015-09-30 郑州大明药物科技有限公司 布洛芬乳膏的制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8623557D0 (en) * 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
CH677606A5 (cg-RX-API-DMAC10.html) * 1988-07-12 1991-06-14 Aesculapius Pharma Sa
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US5055461A (en) * 1989-02-15 1991-10-08 Richardson-Vicks Inc. Anesthetic oral compositions and methods of use
JPH0426618A (ja) * 1990-05-21 1992-01-29 Japan Tobacco Inc トローチ剤
US5024997A (en) * 1990-06-22 1991-06-18 American Home Products Corporation Palatable ibuprofen solutions
JP3069458B2 (ja) * 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
CA2161217A1 (en) * 1993-04-30 1994-11-10 Carmelita Macklin Russell Coated pharmaceutical compositions
US5866162A (en) * 1993-08-10 1999-02-02 Smithkline Beecham P.L.C. Pharmaceutical composition containing a drug/β-cyclodextrin complex in combination with an acid-base couple
US5616344A (en) * 1994-06-14 1997-04-01 Fuisz Technologies Ltd. Apparatus and process for strengthening low density compression dosage units and product therefrom
US5560913A (en) * 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
ATE210428T1 (de) * 1995-10-17 2001-12-15 Reckitt Benckiser Healthcare Geschmacksmaskierte wässrige lösungen enthaltend ibuprofen und menthol
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
US5912007A (en) * 1996-02-29 1999-06-15 Warner-Lambert Company Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same
AU3444297A (en) * 1996-07-12 1998-02-09 Novartis Consumer Health S.A. Oral pharmaceutical combinations of nsaids with terpenoids
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
ES2224634T3 (es) * 1998-04-29 2005-03-01 Sumitomo Pharmaceuticals Company, Limited Formulacion oral que comprende biguanida y un acido organico.
US20020110581A1 (en) * 1999-04-06 2002-08-15 Ream Ronald L. Over-coated product including consumable center and medicament
US20050042271A1 (en) * 1999-11-19 2005-02-24 Xel Herbaceuticals, Inc . Transdermal delivery system for alkaloids of aconitum species
ES2171110B1 (es) * 2000-03-03 2003-06-16 Aplicaciones Farmacodinamicas Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.
WO2003009834A1 (en) * 2000-08-17 2003-02-06 Battey Alyce S Oral delivery of pharmaceuticals via encapsulation
KR100762115B1 (ko) * 2000-08-25 2007-10-04 코와 가부시키가이샤 이부프로펜 캡슐 충전액 및 캡슐 제제
IT1319229B1 (it) * 2000-10-20 2003-09-26 Savio Macchine Tessili Spa Dispositivo portarocche perfezionato per avvolgimento di filato conpressione regolata, particolarmente per ritorcitoi a doppia torsione.
US20040147606A1 (en) * 2001-05-25 2004-07-29 Yoichi Onuki Medicinal compositions
US8859028B2 (en) * 2002-06-14 2014-10-14 Cereal Ingredients, Inc. Coated food particle and method for making a swirl
GB0217382D0 (en) * 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
US20040071852A1 (en) * 2002-10-09 2004-04-15 Yael Vodovotz Compositions and processes for making high soy protein-containing bakery products
CA2501741C (en) * 2002-10-11 2012-04-17 Novozymes A/S Method of preparing a heat-treated product
JP4815867B2 (ja) * 2004-05-11 2011-11-16 大正製薬株式会社 安定化された固形製剤
US20060263475A1 (en) * 2004-08-25 2006-11-23 Cadbury Adams Usa, Llc. Center-filled chewing gum composition
BRPI0519212A2 (pt) * 2004-12-23 2009-01-06 Mcneil Ppc Inc composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial
EP1942877A4 (en) * 2005-11-02 2011-09-14 Teikoku Pharma Usa Inc ORGANOLEPTICALLY ACCEPTABLE ORAL DOSAGE FORMS OF IBUPROFEN, MANUFACTURING METHOD AND APPLICATION

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2567050C2 (ru) * 2011-07-01 2015-10-27 Сино-Американ Тяньцзинь Смитклайн Энд Френч Лаб., Лтд Жевательная таблетка ибупрофена

Also Published As

Publication number Publication date
TW200733954A (en) 2007-09-16
WO2007055887A1 (en) 2007-05-18
EP1942877A1 (en) 2008-07-16
JP2009514857A (ja) 2009-04-09
AU2010202050A1 (en) 2010-06-10
AU2006312119A1 (en) 2007-05-18
KR20080034166A (ko) 2008-04-18
JP2012255018A (ja) 2012-12-27
CA2620219A1 (en) 2007-05-18
RU2012138581A (ru) 2014-03-20
US20070098789A1 (en) 2007-05-03
AR056749A1 (es) 2007-10-24
CN103622926A (zh) 2014-03-12
EP1942877A4 (en) 2011-09-14
BRPI0618273A2 (pt) 2011-08-23
AU2006312119B2 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
RU2012138581A (ru) Органолептически приемлемая пероральная лекарственная форма ибупрофена и способы ее приготовления и применения
MC1416A1 (fr) Compositions orales contenant de l'hexetidine et des sels de zinc pour l'inhibition synergique de la plaque dentaire
JP2007332143A (ja) 口臭を抑える抗菌作用を持った化合物
JP6522877B2 (ja) 口腔用組成物
RU2460510C2 (ru) Шипучие композиции
JP6316825B2 (ja) チューインガム
CN102448437B (zh) 用于缓解唾液分泌过少和提供口腔舒适的组合物和方法
KR102153638B1 (ko) 구강 향미제 조성물
KR102181718B1 (ko) 연마제가 무함유된 발포성 고체 구강청결제
KR101122174B1 (ko) 비스테로이드성 소염제를 포함하며 우수한 기호성을 가진약학적 경구 제제
JP2006117574A (ja) 液体口腔用組成物
JPH09194356A (ja) 鉄化合物配合内服液剤
CN103596544B (zh) 口腔清洗剂组合物
JP2020169150A (ja) 口腔用組成物
RU2524631C2 (ru) Изменение цвета содеращих халкон препаративных форм по уходу за ротовой полостью
CN118526416B (zh) 一种抑菌爆珠牙膏制剂及其在制备口腔药物中的用途
JP2012107060A (ja) イソソルビドの苦味が軽減された経口製剤及びその製造方法
EP3644943A1 (en) Composition comprising an antiseptic, a volatile sulfur compound neutralizer, and an anticariogenic agent
WO2026104682A1 (en) Paeonol as a suppressor of volatile sulfur compound bacterial metabolites and for use in the treatment of diseases caused by bacteria producing volatile sulfour compounds (vsc) metabolites in the oral cavity and/or digestive system
JP2025089684A (ja) シトルリン低減剤
DE202014009184U1 (de) Gel für die Mundhöhle
KR20250006092A (ko) 구강건조증 치료를 위한 신규한 구강 관리 제형
UA136727U (uk) Фармацевтична композиція у формі гумки жувальної лікувальної для застосування у стоматології
UA122936C2 (uk) Фармацевтична композиція у формі гумки жувальної лікувальної для застосування у стоматології
CN101262854A (zh) 感官上可接受的布洛芬口服给药制剂、制备和使用它的方法